Literature DB >> 25153011

Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995-2008.

Reda J Wilson, M E O'Neil, E Ntekop, Kevin Zhang, Y Ren.   

Abstract

BACKGROUND: Calculating accurate estimates of cancer survival is important for various analyses of cancer patient care and prognosis. Current US survival rates are estimated based on data from the National Cancer Institute's (NCI's) Surveillance, Epidemiology, and End RESULTS (SEER) program, covering approximately 28 percent of the US population. The National Program of Cancer Registries (NPCR) covers about 96 percent of the US population. Using a population-based database with greater US population coverage to calculate survival rates at the national, state, and regional levels can further enhance the effective monitoring of cancer patient care and prognosis in the United States. The first step is to establish the coding completeness and coding quality of the NPCR data needed for calculating survival rates and conducting related validation analyses.
METHODS: Using data from the NPCR-Cancer Surveillance System (CSS) from 1995 through 2008, we assessed coding completeness and quality on 26 data elements that are needed to calculate cancer relative survival estimates and conduct related analyses. Data elements evaluated consisted of demographic, follow-up, prognostic, and cancer identification variables. Analyses were performed showing trends of these variables by diagnostic year, state of residence at diagnosis, and cancer site.
RESULTS: Mean overall percent coding completeness by each NPCR central cancer registry averaged across all data elements and diagnosis years ranged from 92.3 percent to 100 percent. RESULTS showing the mean percent coding completeness for the relative survival-related variables in NPCR data are presented. All data elements but 1 have a mean coding completeness greater than 90 percent as was the mean completeness by data item group type. Statistically significant differences in coding completeness were found in the ICD revision number, cause of death, vital status, and date of last contact variables when comparing diagnosis years. The majority of data items had a coding quality greater than 90 percent, with exceptions found in cause of death, follow-up source, and the SEER Summary Stage 1977, and SEER Summary Stage 2000.
CONCLUSION: Percent coding completeness and quality are very high for variables in the NPCR-CSS that are covariates to calculating relative survival. NPCR provides the opportunity to calculate relative survival that may be more generalizable to the US population.

Entities:  

Mesh:

Year:  2014        PMID: 25153011      PMCID: PMC4369759     

Source DB:  PubMed          Journal:  J Registry Manag        ISSN: 1945-6131


  7 in total

Review 1.  Interpreting trends in cancer patient survival.

Authors:  P W Dickman; H-O Adami
Journal:  J Intern Med       Date:  2006-08       Impact factor: 8.989

2.  Rationale and design of the National Program of Cancer Registries' Breast, Colon, and Prostate Cancer Patterns of Care Study.

Authors:  Kathleen McDavid; Maria J Schymura; Lori Armstrong; Loretta Santilli; Beth Schmidt; Tim Byers; C Brooke Steele; Lilia O'Connor; Nancy C Schlag; Winny Roshala; Dottie Darcy; Genevieve Matanoski; Tiefu Shen; Susan Bolick-Aldrich
Journal:  Cancer Causes Control       Date:  2004-12       Impact factor: 2.506

3.  Evaluating quality of census tract data in the NPCR dataset.

Authors:  Simple Singh; Umed A Ajani; Reda J Wilson; Cheryll C Thomas
Journal:  J Registry Manag       Date:  2009

4.  Quality of cancer registry data: findings from CDC-NPCR's Breast and Prostate Cancer Data Quality and Patterns of Care Study.

Authors:  Robert R German; Jennifer M Wike; Katrina R Bauer; Steven T Fleming; Amy Trentham-Dietz; Mary Namiak; Lyn Almon; Karen Knight; Carin Perkins
Journal:  J Registry Manag       Date:  2011

5.  Reporting cutaneous melanoma to cancer registries in the United States.

Authors:  H Irene Hall; Patricia Jamison; John P Fulton; Gayle Clutter; Steven Roffers; Pam Parrish
Journal:  J Am Acad Dermatol       Date:  2003-10       Impact factor: 11.527

6.  Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries.

Authors:  Kathleen K Thoburn; Robert R German; Mary Lewis; Phyllis Janie Nichols; Faruque Ahmed; Jeannette Jackson-Thompson
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860

7.  Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models.

Authors:  Therese M L Andersson; Paul W Dickman; Sandra Eloranta; Paul C Lambert
Journal:  BMC Med Res Methodol       Date:  2011-06-22       Impact factor: 4.615

  7 in total
  12 in total

1.  Relative survival analysis using the Centers for Disease Control and Prevention's National Program of Cancer Registries Surveillance System Data, 2000-2007.

Authors:  Reda J Wilson; A Blythe Ryerson; Kevin Zhang; Xing Dong
Journal:  J Registry Manag       Date:  2014

Review 2.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.

Authors:  Quinn T Ostrom; Haley Gittleman; Gabrielle Truitt; Alexander Boscia; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2018-10-01       Impact factor: 12.300

3.  CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.

Authors:  Quinn T Ostrom; Haley Gittleman; Peter Liao; Toni Vecchione-Koval; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2017-11-06       Impact factor: 12.300

4.  Capture of tobacco use among population-based registries: Findings from 10 National Program of Cancer Registries states.

Authors:  David A Siegel; S Jane Henley; Jennifer M Wike; A Blythe Ryerson; Christopher J Johnson; Judy R Rees; Lori A Pollack
Journal:  Cancer       Date:  2018-03-26       Impact factor: 6.860

Review 5.  Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians.

Authors:  Justin T Low; Quinn T Ostrom; Gino Cioffi; Corey Neff; Kristin A Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neurooncol Pract       Date:  2022-02-22

6.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019.

Authors:  Quinn T Ostrom; Mackenzie Price; Corey Neff; Gino Cioffi; Kristin A Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2022-10-05       Impact factor: 13.029

7.  CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.

Authors:  Quinn T Ostrom; Mackenzie Price; Katherine Ryan; Jacob Edelson; Corey Neff; Gino Cioffi; Kristin A Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2022-09-06       Impact factor: 13.029

8.  Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study.

Authors:  Rin Ogiya; Naoki Niikura; Hiraku Kumamaru; Yoshinori Takeuchi; Takuho Okamura; Takayuki Kinoshita; Kenjiro Aogi; Keisei Anan; Kotaro Iijima; Takanori Ishida; Takayuki Iwamoto; Masaaki Kawai; Yasuyuki Kojima; Takashi Sakatani; Yasuaki Sagara; Naoki Hayashi; Hideji Masuoka; Masayuki Yoshida; Hiroaki Miyata; Hitoshi Tsuda; Shigeru Imoto; Hiromitsu Jinno
Journal:  Breast Cancer Res Treat       Date:  2020-08-20       Impact factor: 4.872

9.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

10.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.

Authors:  Quinn T Ostrom; Nirav Patil; Gino Cioffi; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2020-10-30       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.